Abstract
Introduction
Platelets have a key role in the pathophysiology of acute ST-elevation myocardial infarction (STEMI), and also in the progression of atherosclerosis. Platelet indices have been investigated as prognostic markers in coronary artery disease (CAD). Activated platelets have a higher volume, and mean platelet volume (MPV) has been extensively studied in relation to CAD and acute myocardial infarction. A higher MPV has been associated with more extensive myocardial necrosis and subsequent heart failure [1] , increased incidence of myocardial no-reflow, as well as mortality [2] in patients presenting with STEMI. Platelet-large cell ratio (P-LCR) and platelet distribution width (PDW) have also been associated with impaired reperfusion in patients with STEMI [3, 4] . In recent years, platelet-to-lymphocyte ratio (PLT/LYM) and platelet-to neutrophil ratio (PLT/NEU) have been investigated as predictors of no-reflow in STEMI [5] .
The severity of chronic CAD is also an important prognostic factor in STEMI. Thrombocytes contribute significantly to the progression of atherosclerosis, mainly due to their proinflammatory effects by recruiting white blood cells (WBC) at vascular injury sites, thus directly amplifying plaque burden [6] .
Coronary chronic total occlusion (CTO) is caused by organized thrombi or atherosclerotic plaque progression [7] . A CTO, defined as complete occlusion of a coronary artery branch for at least 3 months, is identified in 15 to 30% of patients referred for a coronary angiography [8] . The presence of a CTO has been shown to be an important negative prognostic factor for allcause mortality and cardiovascular death in patients presenting with ST-elevation myocardial infarction (STEMI), independent of the presence of atherosclerotic multiple vascular disease [9] .
A recent study found a significant association between MPV and the presence of CTO in acute coronary syndrome patients [10] . In our knowledge, there is no specific risk stratification tool to predict the presence of a CTO in STEMI patients. A routinely performed analysis, such as the whole blood count determined on hospital admission in all STEMI patients, would be a 
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Methods
Patients admitted consecutively to the Emergency Institute for Cardiovascular Diseases and Transplantation Tîrgu Mureș for ST-elevation myocardial infarction (STEMI) between January 2011-December 2013 were retrospectively included according to the following criteria: (1) acute STEMI according to the European Society of Cardiology Guideline for Definition of Acute Myocardial infarction, (2) treatment with primary percutaneous coronary intervention (PCI) in the first 12 hours after symptom onset or in 12 to 24 hours in case of ongoing ischemia. Patients with incomplete paraclinical data were excluded, as were patients with a history of coronary artery by-pass surgery or unreadable electrocardiographic tracings: left bundle branch block or pace-maker rhythm. All data was gathered from clinical on-paper and electronic files. The study protocol complied with the declaration of Helsinki and was approved by the local Ethics Committee. Every patient/legal representative signed an informed consent form on personal data usage in scientific purposes on hospital admission.
The chronologic first laboratory measurements performed in the Emergency Department were included in the analysis. For complete blood count determination a SYSMEX KX-21N analyzer was used. Comparability of the measured parameters was estimated by reviewing the laboratory's internal quality control measurements. MPV, PDW and P-LCR were calculated as previously described [11] , with normal ranges between 7.4-11.8 fL, 10.0-22.0 fL and 13-43% respectively. Platelet-to-lymphocyte ratio was calculated by dividing the platelet count to the lymphocyte count.
Chronic total occlusions were identified on the basis of emergency coronary angiograms. The recordings were reviewed by two interventional cardiologists blinded to clinical and laboratory data. A CTO was considered if anterograde flow was absent in a non-infarct related coronary artery, having a diameter of at least 1.5 mm, with distal filling of the lumen through collateral circulation. Patients were divided in two groups according to the presence (CTO+ group) or absence (CTO-group) of a CTO.
Statistical analysis was done using MedCalc Statistical Software version 15.4 (MedCalc Software bvba, Ostend, Belgium; https://www. medcalc.org; 2015). Categorical data were expressed as numbers (percentage) and compared with Fischer's exact test. Continuous data were reported as mean ± SD or median (interquartile range) and analyzed with the help of unpaired t test or Mann-Whitney test, as appropriate. Normal distribution was evaluated by the Kolmogorov-Smirnoff test. Receiver-operating characteristic (ROC) curve analysis was used to test the predictive power and to determine cut-off values of different platelet indices for the presence of CTO. In order to identify the independent predictors of CTO, those clinical/paraclinical variables that presented a significant association with the occurrence of this angiographic finding with a probability level < 0.1 in univariate analysis, were included in a multivariate logistic regression model. All tests were two-tailed and a p value < 0.05 was considered as statistically significant.
Results
A total number of 334 patients were included in the present study, 48 patients (14.37%) in the CTO+ group and 286 (85.63%) in CTOgroup. Except for diabetes mellitus, the groups were similar regarding cardiovascular risk factors (Table I) . For the laboratory measurements, the maximum coefficients of variance during the study period were 4.47% for WBC count and 7.05% for PLT count. In univariate analysis, MPV, PDW and P-LCR were significantly larger in patients with CTO. Whereas PLT/LYM was significantly lower in patients with CTO, no difference was observed between the two groups regarding PLT/NEU (Table I) .
Receiver Multivariate logistic regression analysis identified the PLT/LYM as an independent predictor for CTO (Table 1) ; values of this ratio situated below 97.73 were associated with the incidence of a CTO with an OR of 2.2 (95%CI 1.15-4.2, p=0.02).
Discussion
The main finding of the present study was that the presence of a CTO -an independent determinant of worse short-and long-term outcomes after STEMI -is predicted by simple parameters available on the complete blood count determined at hospital admission: platelet indices and PLT/LYM.
Table I. Baseline clinical parameters and laboratory measurements of the enrolled patients. Values are presented as medians (interquartile range) or number (percentage). Mann-Whitney and Chi-square tests were used as univariate analysis. WBC -white blood cell count; MPV -mean platelet volume; P-LCRplatelet-large cell ratio; PDW -platelet distribution width; PLT/LYM -platelet-to-lymphocyte ratio; PLT/
NEU -platelet-to-neutrophil ratio. 
Platelet indices and CTO
In our study, patients presenting with STEMI who associated CTO had higher MPV than patients without CTO. Kurtul et al. [10] recently published similar results, showing a strong independent association between CTO and MPV. In that study, patients with acute coronary syndromes with and without ST-segment elevation were included, and a cut-off value of 8.65fL for MPV was found to have a high sensitivity and specificity. In our study a cut-off value of 10.2fL was determined for STEMI patients. As the MPV normal range is between 7.4fL and 11fL, a higher cut-off value seems to be more feasible for risk prediction.
The proportion of platelets with an MPV higher than 12 fL is reflected by P-LCR. Compared to healthy controls, P-LCR is higher in patients with acute myocardial infarction and unstable angina [12, 13] . None of the published studies correlating platelet indices with CAD and especially with STEMI present data on the associations between CTO and P-LCR. In our study, high P-LCR was a predictor of CTO. Another important marker of platelet size and activation is PDW [14] . Our results show that in patients presenting with STEMI, PDW can predict the presence of CTO. The association between CTO and PDW has also been showed by Vatankulu et al. [15] in patients with stable CAD who underwent coronary artery angiography. De Luca et al. [16] found no association between PDW and the extent of CAD, but patients with three vessels affected had a tendency towards higher PDW values.
It has been observed that as MPV [17] and PDW [16] are higher, the platelet count is lower, probably due to increased platelet consumption and compensatory production of platelets in the bone marrow [17] . This might suggest that the increase in PDW in our patients is not only due to the acute event, but is also probably a marker of chronic inflammation and high platelet turnover. We observed a statistical trend for lower platelet count in the CTO+ group, as did Kurtul et al [10] . This may emphasize the role of chronic inflammation causing the progression of atherosclerosis towards CTO [18] .
Platelet-to-lymphocyte ratio as an independent predictor of CTO in STEMI patients
During the atherosclerotic process, lymphocytes, especially T cells are recruited in the vessel wall together with macrophages. T cells become activated and amplify the inflammatory response, contributing to the progression of atherosclerosis [18] . In our study, low PLT/LYM was a strong independent predictor of CTO. This combined marker has been investigated recently in multiple studies as a marker of more severe atherosclerosis and outcomes after elective and emergency PCI. A high PLT/LYM was associated with more complex CAD in patients with acute coronary syndromes [19, 20] , and with complete occlusion of the infarct related artery in patients with STEMI [21] . In a recent study a higher incidence of CTO was found in patients with a PLT/LYM greater than 116 [19] . These observations are in contrast with our findings. It was hypothesized that in patients with acute coronary syndromes the lymphocyte count is lower due to stress-induced cortisol secretion [20] . However, higher cortisol levels would further decrease the production of lymphocytes but already circulating cells could not instantly decrease in numbers. In our study, the blood for whole blood cell count was harvested in less than 24 hours after the onset of ischemic symptoms. Interestingly, both high [21] and low [22] lymphocyte counts have been associated with cardiovascular risk factors.
Furthermore, as MPV, PDW and P-LCR were associated with CTO and as they are inversely correlated with platelet count, PLT/LYM was also expected to be lower in patients with CTO.
This study has some limitations. Firstly, due to the retrospective design, data on previous antiplatelet treatment were not available. Also, the time frame between onset of pain and blood sampling ranged between 1 and 24 hours, which might have influenced our results. Our hypothesis-generating findings should be further confirmed by prospective clinical studies.
Conclusion
Platelet indices such as MPV, PDW and P-LCR can predict the presence of CTO in patients presenting with STEMI. A lower PLT/ LYM was also associated with CTO. These parameters could be used in order to stratify risk in patients with STEMI. A prospective study to assess the changes of these parameters in time would help better understand their role as predictors of CAD progression.
